I highly doubt the acquisition theory, however I did find it curious in the super stock webinar that the reason New York called about leronlimab is because a former Gilead scientist at that location thought it would work(per NPs response to a question on how the new York connection came about). That tells me big pharma are not ignorant of cydys existence and what leronlimab can do.